Objective: Cathepsins are lysosomal proteases involved in extracellular matrix remodeling, angiogenesis, and immune regulation. Evidence on serum cathepsin B (Cat B) and cathepsin D (Cat D) levels during pregnancy remains limited and inconsistent, particularly in the Balinese population. This study compared serum Cat B and Cat D levels across pregnancy trimesters and in nonpregnant women. Methods: This analytical cross-sectional study included 96 women, with 24 participants in each group: first trimester, second trimester, third trimester, and nonpregnant controls. Serum Cat B and Cat D levels were measured using enzyme-linked immunosorbent assay. Data were analyzed using one-way analysis of variance or the Kruskal-Wallis test, followed by post hoc analysis. Results: Baseline characteristics were comparable across groups. Serum Cat B levels were significantly higher in pregnant women than in nonpregnant controls (P=0.002). Post hoc analysis confirmed significantly higher Cat B levels in all trimesters than in nonpregnant women, with no significant differences among trimesters. Cat D levels were not normally distributed (P<0.001). Median Cat D levels were highest in the third trimester (P<0.001), whereas no significant differences were observed among the other three groups. Conclusion: Cat B levels were elevated throughout pregnancy without trimester-specific variation, whereas Cat D levels increased markedly in the third trimester. The trimester-related patterns observed in this study are consistent with previous findings; however, absolute Cat B and Cat D levels differed across populations. Further studies are warranted to clarify the mechanistic and endocrine associations of these biomarkers during pregnancy.
No takes yet. Share an insight, caveat, or question.
Kusuma et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: